Day: May 7, 2021

Rafarma Pharmaceuticals, IncCity Scientific University of IstanbulNicosia, Cyprus, May 07, 2021 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that RAFA is in active meetings the City Scientific University of Istanbul (Turkey) (https://cerrahpasa.istanbulc.edu.tr) to establish a nuclear medicine and proton therapy center at the university. In developed countries, up to 70% of cancer patients undergo proton therapy annually and Rafarma received presentations from Modern Nuclear Technologies LLC on the trends and advantages of this therapy in the treatment of malignant tumors. Proton therapy precisely targets even the most difficult to treat tumors and allows higher doses of radiation to be delivered with fewer side effects. Unlike treatment with conventional X-ray therapy, treatment...

DENVER, CO, May 07, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — CBD Global Sciences Inc. (CSE: CBDN) (the “Company“) is pleased to announce that further to its press release dated April 14, 2021, the Company’s principal regulator, the Alberta Securities Commission, has accepted the Company’s application for, and granted, a management cease trade order (the “MCTO“). The application for the MCTO was made by the Company due to a delay in the filing of its audited annual financial statements, accompanying management discussion and analysis and related CEO and CFO certifications for the year ended December 31, 2020 (the “Annual Filings”). The Company is actively working with its auditors to file the Annual Filings, which the Company expects to be completed in due course. During the period in which...

TORONTO, May 07, 2021 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL)(ASX:KLA) reports that at the annual general meeting of shareholders held on May 6, 2021, all resolutions proposed to shareholders were duly passed. Based on proxies received, 187,602,914 common shares of the Company, representing 70.25% of the Company’s issued and outstanding common shares as at the record date were voted, and the following individuals were elected as directors of the Company until the next annual meeting of shareholders. The results are set out below:Name of Nominee Votes cast FOR % Votes cast FOR Votes WITHHELD % of Votes WITHHELDJonathan Gill 157,320,919 92.26% 13,199,115 7.74%Peter Grosskopf 143,687,337 84.26% 26,832,697 15.74%Ingrid Hibbard 126,865,542 74.40% 43,654,493 25.60%Arnold...

ATHENS, Greece, May 07, 2021 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Bocimar International N.V., for one of its Kamsarmax dry bulk vessels, the m/v Myrsini. The gross charter rate is US$27,750 per day, minus a 5% commission paid to third parties, for a time charter period until minimum October 15, 2021 up to maximum November 30, 2021. The charter is expected to commence on May 10, 2021. The m/v Myrsini is currently chartered, as previously announced, to Ausca Shipping Limited, Hong Kong, at a gross charter rate of US$11,500 per day, minus a 5% commission paid to third parties. The “Myrsini” is a 82,117 dwt Kamsarmax...

ANNOUNCEMENT NO. 66 – 7 MAY 2021 Under Article 19 of the Market Abuse Regulation Dampskibsselskabet NORDEN A/S is required to report transactions in Dampskibsselskabet NORDEN A/S’ shares by persons discharging managerial responsibilities and their close relatives.Name:   Jan RindboReason:   Reporting duty, CEOIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:   SharesTransaction:   Purchase of sharesTrading date:   6 May 2021Market:   Nasdaq CopenhagenNumber:   50,000Market value in DKK:   4,725,000Holding after transaction   87,837Reason:   Reporting duty, CEOIssuer:   Dampskibsselskabet NORDEN A/SISIN code:   DK0010269844Instrument:   SharesTransaction:   Sale of sharesTrading date:   6 May 2021Market:   Nasdaq CopenhagenNumber:   20,000Market...

IRVINE, Calif., May 07, 2021 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage,” the “Company,” “we” or “our”), the leading provider of outsourced sales and marketing services to consumer goods manufacturers and retailers, today announced that as a result of recent guidance provided by the U.S. Securities and Exchange Commission on April 12, 2021 relating to the accounting treatment of warrants issued by special purpose acquisition companies (the “SEC Statement”), it will revise its consolidated financial statements previously issued in its Annual Report on Form 10-K for the year ended December 31, 2020 (the “Financial Statements”). The revision pertains to the accounting treatment for certain of our warrants issued in a private placement (the “private placement warrants”) that were outstanding at the time of...

Brentwood, Tenn., May 07, 2021 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC, IMACW), a provider of innovative medical advancements and care specializing in regenerative and rehabilitation orthopedic treatments without the use of surgery or opioids, announced today that management will participate at the Benzinga Global Small Cap Conference on May 13, 2021. Chief Executive Officer Jeffrey Ervin will deliver his corporate presentation at 3:30pm ET on May 13, 2021. Investors can also request a one-on-one meeting with Mr. Ervin to be arranged following the conclusion of the conference. Investors can register for the conference here: https://www.benzinga.com/events/small-cap/global/ About IMAC Holdings, Inc. IMAC was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky...

NEW YORK, May 07, 2021 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May:Bank of America 2021 Healthcare Conference on Wednesday, May 12 at 9:30 a.m. EDT 7th Annual Truist Securities Life Sciences Summit on Thursday, May 20 at 11:00 a.m. EDT UBS Global Healthcare Virtual Conference on Monday, May 24 at 2:00 p.m. EDTThe webcasts will be accessible from Royalty Pharma’s “Events” page at https://www.royaltypharma.com/investors/news-and-events/events. Webcasts will also be archived for a minimum of thirty days. About Royalty Pharma plc Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators...

BEIJING, May 07, 2021 (GLOBE NEWSWIRE) — Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, today announced that Mr. Guocong Zhou had step down as CEO of the Company, effective May 5, 2021. He was succeeded by Ms. Ou Yang, who has extensive experience in the capital market and the healthcare industry, on May 6, 2021. Ms. Ou Yang has served as a partner of Wuhan Sinopharm Optical Valley Capital Management Co., Ltd., a subsidiary of China National Pharmaceutical Group Corporation and an equity investment institution focusing on the medical and healthcare field, since January 2020 and has been responsible for the investment and post-investment management of the funds managed by the company. From May 2014 to December 2019, Ms. Yang...